Race and sex differences in hypertension control in CKD: results from the Kidney Early Evaluation Program (KEEP)

Obidiugwu Kenrik Duru1, Suying Li, Claudine Jurkovitz

  • 1Division of General Internal Medicine/Health Services Research, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA. kduru@mednet.ucla.edu

Insights

African American men with chronic kidney disease (CKD) experience worse hypertension control than other groups, especially in early stages. Addressing this disparity is crucial for slowing CKD progression to end-stage renal disease.

Area of Science:

  • Nephrology
  • Cardiovascular Health
  • Health Disparities

Background:

  • African American men with chronic kidney disease (CKD) face more rapid progression to end-stage renal disease compared to other demographics.
  • Hypertension is a key factor exacerbating CKD, and disparities in its management may drive these unequal outcomes.

Purpose of the Study:

  • To investigate hypertension control rates among African American men with CKD in comparison to women and white individuals.
  • To identify potential race and sex disparities in hypertension management within the CKD population.

Main Methods:

  • A cross-sectional study analyzed data from 10,827 individuals with CKD and hypertension from the Kidney Early Evaluation Program.
  • Predictors examined included African American race and sex.
  • Hypertension control was defined as blood pressure below 130/80 mm Hg, assessed via physical examination and laboratory data.

Main Results:

  • In early-stage CKD, African American women, white men, and white women had significantly higher odds of controlled hypertension compared to African American men.
  • In late-stage CKD, white men and white women also showed greater odds of hypertension control than African American men.
  • No significant differences in hypertension control were observed between African American men and women in the late stages of CKD.

Conclusions:

  • African American men with CKD exhibit poorer hypertension control, particularly in the early disease stages, compared to other demographic groups.
  • Targeted interventions to aggressively manage hypertension in African American men with CKD are recommended to reduce disparities in progression to end-stage renal disease.
Abstract

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...